MD Process Launches a New Approach to Blood Sugar Health, GlucoBerry(TM)
Atlanta, Georgia–(Newsfile Corp. – December 22, 2022) – Health formula developer MD Process launches GlucoBerry™,…
Atlanta, Georgia–(Newsfile Corp. – December 22, 2022) – Health formula developer MD Process launches GlucoBerry™,…
LAUSANNE, Switzerland–(BUSINESS WIRE)–#cancersurgery–SamanTree Medical, a medical technology company driven to support clinicians with their intraoperative…
insightsoftware recognized as an Embedded BI leader in 10th annual report RALEIGH, N.C.–(BUSINESS WIRE)–insightsoftware, a…
UNIONDALE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a biopharmaceutical company…
Internet City, Dubai–(Newsfile Corp. – December 21, 2022) – LBank Exchange, a global digital asset…
TOKYO and BANGKOK, Dec 22, 2022 – (JCN Newswire) – Opn, the global one-stop payment…
ZURICH, SWITZERLAND, Dec 22, 2022 – (JCN Newswire) – Hitachi Energy and Linxon are collaborating…
TOKYO, Dec 22, 2022 – (JCN Newswire) – Fujitsu’s quantum-inspired solution, Digital Annealer, has achieved…
ADS-TEC Energy to invest $8 million dollars in sales, warehousing, service and assembly facility, creating…
The plant will produce over 1,400 cubic meter per hour (m3/hr) of desalinated seawater to…
–Deb Frodl and Sarah Sclarsic Transition off Board Effective December 31, 2022– –Chris Hayes Elected…
Wenxian, China–(Newsfile Corp. – December 21, 2022) – On December 17, 2022, under the guidance…
World’s first commercial-scale facility to convert waste gases into sustainable aviation fuel expected to produce…
ORIC and Pfizer have entered into a clinical development collaboration for a Phase 2 study…
Positive Dupixent®(dupilumab) Phase 3 results in adults and adolescents with eosinophilic esophagitis published in the…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant…
Company Intends to Hold FY 2022 Annual Meeting in February 2023 NEW YORK, Dec. 21,…
LX9211.202 ADPS Results: Separation from Placebo Was Seen by Week 1 in LX9211 Treatment Arm…
WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…